Showing results (21-30 of 61) with videos related to

Sort By:
Pageof 7
AIDS (London, England)|April 20, 2010
HIV+ elite controllers have low HIV-specific T-cell activation yet maintain strong, polyfunctional T-cell responsesRachel E Owen, John W Heitman, Dale F Hirschkorn, et al.
The Journal of Infectious Diseases|April 22, 2008
Comprehensive analysis of west nile virus-specific T cell responses in humansMarion C Lanteri, John W Heitman, Rachel E Owen, et al.
The Journal of Infectious Diseases|November 27, 2014
Downregulation of Cytokines and Chemokines by GB Virus C After Transmission Via Blood Transfusion in HIV-Positive Blood RecipientsMarion C Lanteri, Farnaz Vahidnia, Sylvia Tan, et al.
Transfusion|June 27, 2014
West Nile virus nucleic acid persistence in whole blood months after clearance in plasma: implication for transfusion and transplantation safetyMarion C Lanteri, Tzong-Hae Lee, Li Wen, et al.
Open Forum Infectious Diseases|April 30, 2025
Proportions of US Blood Donors With Serological Evidence of Severe Acute Respiratory Syndrome Coronavirus 2 Infections Who Reported Survey-Based Diagnosed Infections During July 2020-December 2022Akintunde Akinseye, David J Wright, Eduard Grebe, et al.
Plos One|March 20, 2014
Increased frequency of Tim-3 expressing T cells is associated with symptomatic West Nile virus infectionMarion C Lanteri, Michael S Diamond, Jacqueline P Law, et al.
AJPM Focus|February 2, 2024
Associations of Temporal Cardiometabolic Patterns and Incident SARS-CoV-2 Infection Among U.S. Blood Donors With Serologic Evidence of VaccinationElaine A Yu, Mars Stone, Marjorie D Bravo, et al.
The Journal of Infectious Diseases|August 30, 2008
Interferon and interferon-induced chemokine expression is associated with control of acute viremia in West Nile virus-infected blood donorsLeslie H Tobler, Mark J Cameron, Marion C Lanteri, et al.
Plos Pathogens|December 5, 2012
IL-1β signaling promotes CNS-intrinsic immune control of West Nile virus infectionHilario J Ramos, Marion C Lanteri, Gabriele Blahnik, et al.
Transfusion|July 10, 2024
SARS-CoV-2 antibody levels and long COVID occurrence in blood donorsVivian I Avelino-Silva, Roberta Bruhn, Karla G Zurita, et al.
Pageof 7